Malignant Skin Tumors Juraj Hegyi LF MU Nonmelanoma skin cancer (NMSC) ● Basal cell carcinoma ● Squamous cell carcinoma ● Actinic keratosis ● Angiosarcoma ● Dermatofibrosarcoma protuberans ● Merkel cell carcinoma ● Sebaceus gland carcinoma ● Skin metastasis ● T and B cell lymphoma 2 Basal cell carcinoma (BCC) ● First mentioned by Jacobsom in 1824 ● More common than melanoma ● Yearly increase in incidence worldwide ● Incidence doubles every 25 years ● 19 x more common in caucasians ● 26 distinct sub types... 3 Basal cell carcinoma (BCC) ● ● ● ● Originates from pluripotent cells of the basal layer of the epidermis and the terminal hair follicle A slow-growing tumor with virtually no potential to establish metastases Grows locally destructively Nodular, superficial, with pigment, sclerodermiform, infiltrative, fibroepithelial (Pinkus), metatypical 4 Basal cell carcinoma (BCC) risk factors ● UV radiation, mainly UVB, less UVA (melanoma) – The probability of occurrence increases in direct proportion to the cumulative dose of UV radiation – The latency period from radiation to clinical manifestation is about 20-30 years – Exterior workers ↑ risk – Frequent occurrence in the H line 5 Basal cell carcinoma (BCC) risk factors ● Phototype of the skin, geographical location. ● Immunosuppression ● Mainly transplanted patients ● ● Genetic factors (Gorlin sy., Xeroderma pigmentosum) Carcinogens (arsenic) 6 Xeroderma pigmentosum 7 Nodular BCC ● The most common form (60%) ● Location mainly neck and head ● Shiny, rigid papule, or knot with telangiectasias ● Gradually central depression with bulging edges (painless), ulcus rodens 8 Nodular BCC 9 Superficial BCC ● Makes up about 15 - 30% ● Location mainly torso and limbs ● Easily infiltrated, sharply demarcated bearings ● Sometimes desquamation and hemorrhagic crust formation 10 Superficial BCC 11 Pigmented BCC ● The structure most often resembles nBCC ● Pigmented areas ● Diff. dg. Malignant melanoma should be considered 12 Pigmented BCC 13 Therapy ● Invasive methods ● Surgical excision ● Mohs surgery ● Cryotherapy ● Curettage ● Non-invasive methods ● PDT ● 5% imiquimod (Aldara), 5% fluorouracil (Effudix) ● Brachytherapy 14 Squamous cell carcinoma (SCC) ● The second most common skin cancer (approx. 20%) ● Epithelial tumor with intraepithelial growth ● It is relatively invasive ● In places of solar damage, or burns or chronic extensive scarring ● 70% head and neck ● It metastasizes via lymphatic system 15 SCC risk factors ● Age over 50 and male ● Low phototype ● UV exposure ● Chronic skin changes ● HPV ● Chemical carcinogens ● Ionizing radiation 16 SCC ● Several clinical forms ● M. Bowen ● Erythroplasia de Queyrat ● Ulcerative SCC ● Periungual SCC ● Marjolin ulcer ● AK 17 Therapy ● Radical surgical excision with a protective rim ● Radiotherapy ● Chemotherapy ● Always USG of the lymph nodes 18 SCC 19 SCC 20 SCC 21 SCC 22 Actinic keratosis (AK) ● Very common epidermal dysplasia ● Sites of chronic solar damage ● 6 to 8 decades most often ● About 10% progresses to SCC ● ● Extremely common in immunosuppressed individuals Academic discussion: Ca in situ vs. Precanc. 23 AK 24 AK ● Characteristic for AK is area carcinogenic spread, the so-called “Field cancerization” ● Presence of 6+ AK in a sun-exposed area ● Risk factors as with other NMSCs 25 Therapy ● Prevention, Prevention, Prevention (SPF, etc.) ● May lead to spontaneous regression of AK ● Cryosurgery / curettage ● PDT ● CO2 laser, ER: YAG laser ● 5% imiquimod (Aldara) ● Ingenol mebutate (Picato) 26 AK 27 PDT AK 28 Merkel cell carcinoma ● Rare neuroendocrine carcinoma of the skin ● Fast growing, pink to bluish papule ● ● Based on Merkel cells (associated with receptors for sensory perception) Rapid metastasis (in transit metastasis) 29 Merkel cell carcinoma 30 Dermatofibrosarcoma protuberans ● ● Very rare mesenchymal skin tumor Appearance of scar or protuberation with palpable subcutaneous infiltrate beyond exophytic growth ● 0.8 - 4.5 / 1,000,000 ● More common in blacks ● Local recurrences are common 31 Dermatofibrosarcoma protuberans 32